The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

被引：57
|
作者：
Woelderink, A
Ibarreta, D
Hopkins, MM
Rodriguez-Cerezo, E
机构：
[1] European Commiss, Joint Res Ctr, IPTS, E-41092 Seville, Spain
[2] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England
来源：
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 01期
基金：
英国经济与社会研究理事会;
关键词：
D O I：
10.1038/sj.tpj.6500341
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 7
页数：5
相关论文
共 50 条
  • [21] The HER2 testing conundrum
    Malorye Allison
    Nature Biotechnology, 2010, 28 : 117 - 119
  • [22] Azathioprine and pharmacogenetic testing: Implication in clinical practice
    Le Scanff, J.
    Bavuz, E.
    Le Roux, K.
    Gaultier, J. B.
    Hot, A.
    Guy, C.
    Oilagnier, M.
    Gagnieu, M. C.
    Ninet, J.
    Roussef, H.
    DRUG SAFETY, 2007, 30 (10) : 966 - 967
  • [23] Role of warfarin pharmacogenetic testing in clinical practice
    Tan, Guang-Ming
    Wu, Enoch
    Lam, Yat-Yin
    Yan, Bryan P.
    PHARMACOGENOMICS, 2010, 11 (03) : 439 - 448
  • [24] HER2 testing: a review of detection methodologies and their clinical performance
    Laudadio, Jennifer
    Quigley, Denise I.
    Tubbs, Raymond
    Wolff, Daynna J.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (01) : 53 - 64
  • [25] Herceptin: HER2 status - Changing clinical practice - Introduction
    Piccart, M
    Kaufmann, M
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S1 - S2
  • [26] Pharmacogenetic testing: current evidence of clinical utility
    Moaddeb, Jivan
    Haga, Susanne B.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2013, 4 (04) : 155 - 169
  • [27] HER2 Testing in Endometrial Serous Carcinoma Time for Standardized Pathology Practice to Meet the Clinical Demand
    Buza, Natalia
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 687 - 691
  • [28] Current issues in ER and HER2 testing by IHC in breast cancer
    Gown, Allen M.
    MODERN PATHOLOGY, 2008, 21 : S8 - S15
  • [29] Recommendations for pharmacogenetic testing in clinical practice guidelines in the US
    Hertz, Daniel L.
    Bousman, Chad A.
    McLeod, Howard L.
    Monte, Andrew A.
    Voora, Deepak
    Orlando, Lori A.
    Crutchley, Rustin D.
    Brown, Benjamin
    Teeple, Wrenda
    Rogers, Sara
    Patel, Jai N.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (16) : 672 - 683
  • [30] Recommendations for HER2 testing in the UK
    Ellis, IO
    Dowsett, M
    Bartlett, J
    Walker, R
    Cooke, T
    Gullick, W
    Gusterson, B
    Mallon, E
    Lee, PB
    JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (12) : 890 - 892
12345